Medical Meetings

Medical and scientific conferences are an important forum for the presentation of data relating to our products and pipeline. Below are upcoming or recent meetings at which data related to Alkermes' products or product candidates are being presented.  

163rd Annual Meeting of the American Psychiatric Association (APA), May 22-26, New Orleans, LA

• Poster Presentation #NR7-3, May 26, 2:00 - 3:00 p.m. CT
  “Characteristics, Persistence, and Outcomes of Insured Patients Treated With Extended-Release Naltrexone (XR-NTX) or Oral Medications". Mady Chalk, Ph.D., Leslie Montejano, Ph.D., Tami Mark, Ph.D., Henry R. Kranzler M.D., David R. Gastfriend, M.D.
• Poster Presentation #NR7-6, May 26, 2:00 - 3:00 p.m. CT
  “Efficacy and Safety of Extended-Release Injectable Naltrexone (XR-NTX) for the Treatment of Opioid Dependence". Evgeny Krupitsky, Ari Illeperuma, M.S., David R. Gastfriend, M.D., Bernard L. Silverman, M.D.
• Poster Presentation #NR7-12, May 26, 2:00 - 3:00 p.m. CT
  “Preliminary Evaluation of Extended-Release Naltrexone (XR-NTX) in Michigan and Missouri Drug Courts". Michael W. Finigan, Ph.D., Tamara Perkins, Ph.D., Phyllis Zold-Kilbourn, Ph.D.
• Poster Presentation #NR7-16, May 26, 2:00 - 3:00 p.m. CT
  “Extended-Release Injectable Naltrexone (XRNTX) Reduces Brain Response to Alcohol Cues in Alcohol-Dependent Volunteers: A BOLD fMRI Study". Scott E. Lukas, Ph.D., Steven Lowen, Ph.D., David M. Penetar, Ph.D., Nina Conn, Wendy Tartarini, M.A., John Rodolico, Ph.D., Gopi Mallya, M.D., Christopher Palmer, M.D., Bernard L. Silverman, M.D., David R. Gastfriend, M.D.